Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib.

Quintavalle, Cristina

Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib. [electronic resource] - Cell death & disease 10 2017 - e3138 p. digital

Publication Type: Journal Article

2041-4889

10.1038/cddis.2017.512 doi


Adolescent
Adult
Aged
Aged, 80 and over
Apoptosis Regulatory Proteins
Carcinoma, Hepatocellular--drug therapy
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Child
Drug Resistance, Neoplasm
Humans
Intracellular Signaling Peptides and Proteins--genetics
Liver Neoplasms--drug therapy
Middle Aged
Niacinamide--administration & dosage
Phenylurea Compounds--administration & dosage
Phosphoproteins--genetics
Sorafenib
Transfection
Young Adult